Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies

by Ruurt A. Jukema, Tarek A. N. Ahmed, Jean-Claude Tardif
Published 2019-11-01

Psychological Profiles in the Prediction of Leukocyte Telomere Length in Healthy Individuals.

by Louisia Starnino, Lambert Busque, Jean-Claude Tardif, Bianca D'Antono
Published 2016-01-01

Trait Hostility and Acute Inflammatory Responses to Stress in the Laboratory.

by Dominique Girard, Jean-Claude Tardif, Julie Boisclair Demarble, Bianca D'Antono
Published 2016-01-01

Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease

by Raed Osman, Philippe L L’Allier, Nader Elgharib, Jean-Claude Tardif
Published 2006-09-01

Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?

by Ele Ferrannini, Stephen J Nicholls, Jørgen Rungby, Jean-Claude Tardif, Faiez Zannad
Published 2015-11-01

Assessment of Inter-Expert Variability and of an Automated Segmentation Method of 40 and 60 MHz IVUS Images of Coronary Arteries.

by François Destrempes, Marie-Hélène Roy Cardinal, Yoshifumi Saijo, Gérard Finet, Jean-Claude Tardif, Guy Cloutier
Published 2017-01-01

Optimisation of reference genes for gene-expression analysis in a rabbit model of left ventricular diastolic dysfunction.

by Walid Nachar, David Busseuil, Yanfen Shi, Teodora Mihalache-Avram, Mélanie Mecteau, Eric Rhéaume, Jean-Claude Tardif
Published 2014-01-01

Fabricating Water Dispersible Superparamagnetic Iron Oxide Nanoparticles for Biomedical Applications through Ligand Exchange and Direct Conjugation

by Tina Lam, Pramod K. Avti, Philippe Pouliot, Foued Maafi, Jean-Claude Tardif, Éric Rhéaume, Frédéric Lesage, Ashok Kakkar
Published 2016-05-01

Expression of phosphoinositide-specific phospholipase C isoforms in native endothelial cells.

by Delphine M Béziau, Fanny Toussaint, Alexandre Blanchette, Nour R Dayeh, Chimène Charbel, Jean-Claude Tardif, Jocelyn Dupuis, Jonathan Ledoux
Published 2015-01-01

Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits.

by Walid Nachar, Nolwenn Merlet, Foued Maafi, Yanfen Shi, Teodora Mihalache-Avram, Mélanie Mecteau, Marine Ferron, Eric Rhéaume, Jean-Claude Tardif
Published 2019-01-01

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

by Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox, CLARIFY Investigators
Published 2012-01-01

Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34 Cells from Atherosclerotic Patients with Type 2 Diabetes

by Sylvie Cointe, Éric Rhéaume, Catherine Martel, Olivier Blanc-Brude, Evemie Dubé, Florence Sabatier, Françoise Dignat-George, Jean-Claude Tardif, Arnaud Bonnefoy
Published 2017-02-01

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

by Laurent Fauchier, Nicola Greenlaw, Roberto Ferrari, Ian Ford, Kim M Fox, Jean-Claude Tardif, Michal Tendera, Ph Gabriel Steg, CLARIFY Investigators
Published 2015-01-01

Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

by Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, Michel Komajda, Karl Swedberg, Luigi Tavazzi, Jeffrey S. Borer, Michael Bohm, Ian Ford, Jean‐Claude Tardif
Published 2019-12-01

Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy.

by Mary P McGowan, Jean-Claude Tardif, Richard Ceska, Lesley J Burgess, Handrean Soran, Ioanna Gouni-Berthold, Gilbert Wagener, Scott Chasan-Taber
Published 2012-01-01

Why Rehabilitation must have priority during and after the COVID-19-pandemic: A position statement of the Global Rehabilitation Alliance

by Christoph Gutenbrunner, Emma K. Stokes, Karsten Dreinhöfer, Jan Monsbakken, Stephanie Clarke, Pierre Côté, Isabelle Urseau, David Constantine, Claude Tardif, Venkatesh Balakrishna, Boya Nugraha
Published 2020-07-01

Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure

by Caroline Asselin, Anique Ducharme, Thierry Ntimbane, Matthieu Ruiz, Annik Fortier, Marie-Claude Guertin, Joël Lavoie, Ariel Diaz, Émile Levy, Jean-Claude Tardif, Christine Des Rosiers
Published 2014-01-01

Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure

by Imad Kassem, Steven Sanche, Jun Li, Guillaume Bonnefois, Marie‐Pierre Dubé, Jean‐Lucien Rouleau, Jean‐Claude Tardif, Michel White, Jacques Turgeon, Fahima Nekka, Simon deDenus
Published 2021-01-01

Long-Chain Acylcarnitines and Monounsaturated Fatty Acids Discriminate Heart Failure Patients According to Pulmonary Hypertension Status

by Maxime Tremblay-Gravel, Annik Fortier, Cantin Baron, Chloé David, Pamela Mehanna, Anique Ducharme, Julie Hussin, Qinghua Hu, Jean-Claude Tardif, Christine Des Rosiers, Jocelyn Dupuis, Matthieu Ruiz
Published 2021-03-01

Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys

by Mathieu R. Brodeur, David Rhainds, Daniel Charpentier, Teodora Mihalache-Avram, Mélanie Mecteau, Geneviève Brand, Evelyne Chaput, Anne Perez, Eric J. Niesor, Eric Rhéaume, Cyrille Maugeais, Jean-Claude Tardif
Published 2017-07-01